Intervention not reported
3‐year overall survival rate (37.2/40.2 mo) · women with locally advanced uterine cervix cancer
The intervention showed no clear difference in 3‐year overall survival rate (37.2/40.2 mo) (low certainty).
1 finding from 1 review
- High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer 2014 · Cochrane Headline outcomes onlyRR 0.95 [0.79, 1.15]1 study · 206 participantsLow